Bokus
Peter J. Dunn, K. K. (Mimi) Hii, Michael J. Krische, Michael T. Williams - Sustainable Catalysis – Challenges and Practices for the Pharmaceutical and Fine Chemical Industries, Övrigt

Övrigt, Engelska, 2013

Sustainable Catalysis – Challenges and Practices for the Pharmaceutical and Fine Chemical Industries

Av Peter J. Dunn, K. K. (Mimi) Hii, Michael J. Krische, Michael T. Williams

1503 kr

Tillfälligt slut

Beskrivning
Covering key areas that are particularly important for the fine chemical and pharmaceutical industries, this book highlights current challenges and encourages greater research into green organic synthesis and catalytic methodology. It uniquely unites academic and industrial contributors for a balanced treatment of current innovations from academia and case studies from industry practice. For each reaction, a description of the current state-of-art is provided, including the scope and limitations, then illustrated with examples. This offers organic and process chemists an invaluable reference for applying key reactions in sustainable catalysis.
Produktinformation
  • Märke: John Wiley & Sons Inc
  • Utgivningsdatum: 2013-05-24
  • Höjd: 171 x 246 x 15 mm
  • Vikt: 984 g
  • Språk: Engelska
  • Förlag: John Wiley & Sons Inc
  • EAN: 9781118354520
Utforska kategorier
Mer om författaren

PETER J. DUNN, PhD, is Global Green Chemistry Lead for Pfizer. Dr. Dunn has played a key role in the development of commercial processes to make several drugs, including Viagra(t), Emselex(t), Revatio(t), and Sampatrilat. K. K. (MIMI) HII, PhD, holds a Readership in Catalysis in the Department of Chemistry at Imperial College London. Her research focuses on the development of sustainable catalytic processes for organic synthesis. MICHAEL J. KRISCHE, PhD, is Director of the Center for Green Chemistry and Catalysis and Robert A. Welch Chair in Science at The University of Texas at Austin. He is the recipient of the Tetrahedron Young Investigator Award, Humboldt Prize, Presidential Green Chemistry Challenge Award, and ACS Elias J. Corey Award. MICHAEL T. WILLIAMS, PhD, is an independent consultant. Previously, he was an executive director at Pfizer and played a key role in the development and commercialization of many drugs, including Zoloft(t), Viagra(t), and Relpax(t).

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.